Prof. Dr. Dr. Götz Gelbrich
Prof. Dr. Dr. Götz Gelbrich
kurzer Lebenslauf
seit 2012 | Professor (W2) für Biometrie und stellvertretender Leiter Lehrstuhl für Klinische Epidemiologie und Biometrie, Universität Würzburg |
2011 | Venia legendi für Medizinische Biometrie und Epidemiologie, Universität Leipzig |
2008 | Promotion zum Dr. rer. med. (summa cum laude), Universität Leipzig |
seit 2003 | Seniorbiometriker des Kompetenznetzes Herzinsuffizienz |
1999-2012 | Biometriker am Zentrum für Klinische Studien Leipzig, Universität Leipzig |
1995 | Promotionspreis der Gesellschaft von Freunden und Förderern der Ernst-Moritz-Arndt-Universität Greifswald e.V. |
1994 | Promotion zum Dr. rer. nat. (summa cum laude), Universität Greifswald |
1990-1999 | wissenschaftlicher Asistent am Institut für Mathematik und Informatik, Universität Greifswald |
1990 | mgr matematyki (mit Auszeichnung), Universität Warschau |
1985-1990 | Diplomstudium der Mathematik, Universität Warschau |
Wissenschaftliche Schwerpunkte
Biometrie, klinische Studien, Studiendesign, klinische Epidemiologie
Hauptpublikationen der letzten Jahre
Kleineidam L, Stark M, Riedel-Heller SG, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, Gelbrich G, Schmidt B; NAKO Investigators, Berger K, Wagner M
The assessment of cognitive function in the German National Cohort (NAKO) - Associations of demographics and psychiatric symptoms with cognitive test performance
World J Biol Psychiatry. 2022 Feb 17:1-15. doi: 10.1080/15622975.2021.2011408
Fleischer, A., Heimeshoff, L., Allgaier, J., Jordan, K., Gelbrich, G., Pryss, R., ... & Rasche, L. (2021).
Is PFS the Right Endpoint to Assess Outcome of Maintenance Studies in Multiple Myeloma? Results of a Patient Survey Highlight Quality-of-Life As an Equally Important Outcome Measure.
Blood, 138, 836
Erhardt A, Gelbrich G, Klinger-König J, Streit F, Kleineidam L, Riedel-Heller SG; NAKO Investigators, Schmidt B, Schmiedek F, Wagner M, Grabe HJ, Rietschel M, Berger K, Deckert J
Generalised anxiety and panic symptoms in the German National Cohort (NAKO)
World J Biol Psychiatry. 2022 Feb 17:1-16. doi: 10.1080/15622975.2021.2011409
Gelbrich G, Morbach C, Deutschbein T, Fassnacht M, Störk S, Heuschmann PU
The Population Comparison Index: An Intuitive Measure to Calibrate the Extent of Impairments in Patient Cohorts in Relation to Healthy and Diseased Populations
International journal of environmental research and public health, 2023 Jan 25;20(3), 2168. doi: 10.3390/ijerph20032168
Sahiti F, Morbach C, Cejka V, Tiffe T, Wagner M, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Impact of cardiovascular risk factors on myocardial work-insights from the STAAB cohort study.
J Hum Hypertens. 2021 Mar 2. doi: 10.1038/s41371-021-00509-4.
Felizitas A Eichner , Götz Gelbrich, Benedikt Weißbrich, Lars Dölken, Oliver Kurzai, Jürgen Deckert, Georg Ertl, Maria Barth, Grit Hein, Hannelore Neuhauser, Caroline Morbach, Stefan Störk, Peter Heuschmann
Seroprävalenz von COVID-19 und psychosoziale Auswirkungen in der Allgemeinbevölkerung: Ergebnisse des STAAB-COVID-One Programms
Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S.
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Infection. 2021 Oct 12:1–11. doi: 10.1007/s15010-021-01707-5. Epub ahead of print.
Morbach C, Sahiti F, Tiffe T, Cejka V, Eichner FA, Gelbrich G, Heuschmann PU, Störk S
Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
PLOS ONE; October 8, 2020. doi: 10.1371/JOURNAL.PONE.0239684
Caroline Morbach , Götz Gelbrich, Theresa Tiffe, Felizitas A Eichner, Martin Christa, Renate Mattern, Margret Breunig, Vladimir Cejka, Martin Wagner, Peter U Heuschmann, Stefan Störk
Prevalence and Determinants of the Precursor Stages of Heart Failure: Results From the Population-Based STAAB Cohort Study
Eur J Prev Cardiol . 2020 May 6;2047487320922636. DOI: 10.1177/2047487320922636. Online ahead of print.
Tiffe T, Morbach C, Rücker V, Gelbrich G, Wagner M, Faller H, Störk S, Heuschmann PU.
Impact of Patient Beliefs on Blood Pressure Control in the General Population: Findings from the Population-Based STAAB Cohort Study.
Int J Hypertens. 2019 Jul 28;2019:9385397. doi: 10.1155/2019/9385397. eCollection 2019.
Müller-Scholden L, Kirchhof J, Morbach C, Breunig M, Meijer R, Rücker V, Tiffe T, Yurdadogan T, Wagner M, Gelbrich G, Bots ML, Störk S, Heuschmann PU
Segment-specific association of carotid-intima-media thickness with cardiovascular risk factors - findings from the STAAB cohort study.
BMC Cardiovasc Disord. 09 Apr ;9():8. doi: 0.8/s8-09-0-0.
Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Holz D, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU; STAAB-Konsortium .
Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV.
Eur J Prev Cardiol. 2019 19. März: 2047487319838218. doi: 10.1177 / 2047487319838218. [Epub vor Druck]
Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Störk S; STAAB-Konsortium, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R.
Variationen kardiovaskulärer Risikofaktoren bei Menschen mit und ohne Migrationshintergrund in Deutschland - Ergebnisse der STAAB-Kohortenstudie.
Int J Cardiol. 2018, 30. Oktober. Pii: S0167-5273 (18) 34130-5. doi: 10.1016 / j.ijcard.2018.10.098. [Epub vor Druck]
Löhr M, Freitag B, Technau A, Krauss J, Monoranu CM, Rachor J, Lutz MB, Hagemann C, Kessler AF, Linsenmann T, Wölfl M, Ernestus RI, Engelhardt S, Gelbrich G, Schlegel PG, Eyrich M
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion.
Cancer Immunology, Immunotherapy volume 67, pages1545–1558(2018). doi: 10.1007/S00262-018-2214-0.
Krone M, Dufner V, Wagner M, Gelbrich G, Ertl G, Heuschmann PU
Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany.
Clin Res Cardiol. 2018 Apr 13. doi: 10.1007/s00392-018-1240-4. [Epub ahead of print]
Morbach C, Gelbrich G, Breunig M, Tiffe T, Wagner M, Heuschmann PU, Störk S.
Impact of acquisition and interpretation on total inter-observer variability in echocardiography: results from the quality assurance program of the STAAB cohort study
The International Journal of Cardiovascular Imaging
Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU
Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Int J Behav Med. 2017 Oct 30. doi: 10.1007/s12529-017-9691-y. [Epub ahead of print]
Tiffe T, Wagner M, Rücker V, Morbach C, Gelbrich G, Störk S, Heuschmann PU
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.
Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jürries F, Messerschmid A, Behnke N, Gröschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Krüger M; Find-AF(RANDOMISED) Investigators and Coordinators.
Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002-9. doi: 10.1016/S1474-4422(17)30002-9. [Epub ahead of print]
Musacchio T, Purrer V, Papagianni A, Fleischer A, Mackenrodt D, Malsch C, Gelbrich G, Steigerwald F, Volkmann J, Klebe S.
Non-Motor Symptoms of Essential Tremor Are Independent of Tremor Severity and Have an Impact on Quality of Life. Tremor Other Hyperkinet Mov (N Y). 2016 Mar 8;6:361. doi: 10.7916/D8542NCH.
Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G;
MOOD-HF Investigators and Committees. Effects of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: The MOOD-HF randomized clinical trial.
JAMA. 2016 Jun 28; 315(24): 2683-93. doi: 10.1001/jama.2016.7635.
Jahandar Lashki D, Zelenak C, Tahirovic E, Trippel T, Kolip P, Busjahn A, Rauchfuß M, Nolte K, Schwarz S, Wachter R, Gelbrich G, Halle M, Pieske B, Herrmann-Lingen C, Edelmann F, Düngen HD.
Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire.
Herz. 2016 Jul 13.
Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S.
Interactions of donor sources and media influence the histo-morphological quality of full-thickness skin models.
Biotechnol J. 2016 Oct; 11(10): 1352-61. doi: 10.1002/biot.201600360.
Wagner M, Tiffe T, Morbach C, Gelbrich G, Störk S, Heuschmann PU; STAAB-Consortium.
Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression - design and rationale of the STAAB cohort study.
Eur J Prev Cardiol. 2016 Nov 22. pii: 2047487316680693.
Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C.
When Does Hearing Loss Occur in Vestibular Schwannoma Surgery? Importance of Auditory Brainstem Response Changes in Early Postoperative Phase.
World Neurosurg. 2016 Nov;95:91-98. doi: 10.1016/j.wneu.2016.07.085.
Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C.
Auditory Monitoring in Vestibular Schwannoma Surgery: Intraoperative Development and Outcome. World Neurosurg. 2016 Dec; 96: 444-53. doi: 10.1016/j.wneu.2016.09.026.
Hartwig M, Gelbrich G (korrespondierender Autor), Griewing B.
Functional orthosis in shoulder joint subluxation after ischaemic brain stroke to avoid post-hemiplegic shoulder-hand syndrome: a randomized clinical trial.
Clin Rehabil. 2012 Sep;26(9):807-16. doi: 10.1177/0269215511432355.
Düngen HD, Musial-Bright L, Inkrot S, Apostolović S, Edelmann F, Lainščak M, Sekularac N, Störk S, Tahirovic E, Tscholl V, Krackhardt F, Loncar G, Trippel TD, Gelbrich G.
Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial. '
Eur J Heart Fail. 2014 Aug;16(8):907-14. doi: 10.1002/ejhf.121.
Gelbrich G, Störk S, Kreißl-Kemmer S, Faller H, Prettin C, Heuschmann PU, Ertl G, Angermann CE.
Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study.
Eur J Heart Fail. 2014 Oct;16(10):1133-41. doi: 10.1002/ejhf.150.
Gelbrich B, Schwerdt, S, Hirsch, A, Dannhauer KH, Tausche E, Gelbrich G.
Verschiedene Gesichter der Altersschätzung. Rechtsmedizin
2015;25(1):7-11.
Gelbrich B, Frerking C, Weiss S, Schwerdt S, Stellzig-Eisenhauer A, Tausche E, Gelbrich G.
Combining wrist age and third molars in forensic age estimation: how to calculate the joint age estimate and its error rate in age diagnostics.
Ann Hum Biol. 2015;42(4):389-96. doi: 10.3109/03014460.2015.1046487.
Gelbrich B, Hirsch A, Dannhauer KH, Gelbrich G.
Agenesis of second premolars and delayed dental maturation. J Orofac Orthop.
2015 Jul;76(4):338-50. doi: 10.1007/s00056-015-0295-3.
Rau T, Düngen HD, Edelmann F, Waagstein F, Lainščak M, Dimković S, Apostolović S, Nešković AN, Haverkamp W, Gelbrich G, Eschenhagen T.
Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Clin Pharmacol Ther. 2012 Jul;92(1):21-8. doi: 10.1038/clpt.2012.18. Erratum in: Clin Pharmacol Ther. 2012 Sep;92(3):397.
Lehmkuhl E, Kendel F, Gelbrich G, Dunkel A, Oertelt-Prigione S, Babitsch B, Knosalla C, Bairey-Merz N, Hetzer R, Regitz-Zagrosek V.
Gender-specific predictors of early mortality after coronary artery bypass graft surgery.
Clin Res Cardiol. 2012 Sep;101(9):745-51. doi: 10.1007/s00392-012-0454-0.
Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen C, Anker SD, Düngen HD.
Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure – insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Int J Cardiol. 2012 Nov 29;161(3):160-5. doi: 10.1016/j.ijcard.2012.06.004.
Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD.
Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial.
Int J Cardiol. 2012 Nov 29;161(3):143-50. doi: 10.1016/j.ijcard.2011.09.007.
Dekleva M, Düngen HD, Gelbrich G, Inkrot S, Suzic Lazic J, Pavlovic Kleut M, Tahirovic E, Waagstein F.
Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure.
CIBIS-ELD sub-study. Aging Clin Exp Res. 2012 Dec;24(6):675-81. doi: 10.3275/8720.
Lainscak M, Farkas J, Inkrot S, Gelbrich G, Neskovic AN, Rau T, Tahirovic E, Töpper A, Apostolovic S, Haverkamp W, Herrmann-Lingen C, Anker SD, Düngen HD.
Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.
Int J Cardiol. 2013 Feb 10;163(1):87-92. doi: 10.1016/j.ijcard.2011.05.037.
Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B;
Aldo-DHF Investigators. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N.
Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.
Clin Res Cardiol. 2013 Mar;102(3):203-13. doi: 10.1007/s00392-012-0519-0.
Schowalter M, Gelbrich G, Störk S, Langguth JP, Morbach C, Ertl G, Faller H, Angermann CE.
Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression.
Clin Res Cardiol. 2013 Apr;102(4):269-78. doi: 10.1007/s00392-012-0531-4.
Lossnitzer N, Herzog W, Störk S, Wild B, Müller-Tasch T, Lehmkuhl E, Zugck C, Regitz-Zagrosek V, Pankuweit S, Maisch B, Ertl G, Gelbrich G, Angermann CE;
Competence Network Heart Failure. Incidence rates and predictors of major and minor depression in patients with heart failure.
Int J Cardiol. 2013 Jul 31;167(2):502-7. doi: 10.1016/j.ijcard.2012.01.062.
Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, Gelbrich G, Hasenfuß G, Stahrenberg R, Liman J, Gröschel K.
Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study.
J Neurol. 2013 Aug;260(8):2042-5. doi: 10.1007/s00415-013-6935-x.
Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, Erbel R, Neumann T.
Valvular manifestations of human immunodeficiency virus infection – results from the prospective, multicenter HIV-HEART study.
J Cardiovasc Med (Hagerstown). 2013 Oct;14(10):733-9. doi: 10.2459/JCM.0b013e32835dc953.
Buder K, Gesierich A, Gelbrich G, Goebeler M.
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Cancer Med. 2013 Oct;2(5):674-86. doi: 10.1002/cam4.133.
Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B.
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction – results of the Aldo-DHF trial.
Int J Cardiol. 2013 Nov 30;169(6):408-17. doi: 10.1016/j.ijcard.2013.10.018.
Apostolovic S, Stanojevic D, Lainscak M, Gelbrich G, Jankovic-Tomasevic R, Pavlovic M, Djordjevic-Radojkovic D, Salinger-Martinovic S, Putnikovic B, Radovanovic S, Waagstein F, Tomasevic M, Tahirovic E, Inkrot S, Musial-Bright L, Düngen HD.
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Cardiol J. 2014;21(3):265-72. doi: 10.5603/CJ.a2013.0117.
Matthies C, Brill S, Varallyay C, Solymosi L, Gelbrich G, Roosen K, Ernestus RI, Helms J, Hagen R, Mlynski R, Shehata-Dieler W, Müller J.
Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?
J Neurosurg. 2014 Feb;120(2):546-58. doi: 10.3171/2013.9.JNS12686.
Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA.
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.
Eur Heart J. 2014 Apr;35(16):1069-77. doi: 10.1093/eurheartj/eht251.
Weber-Krüger M, Gelbrich G, Stahrenberg R, Liman J, Kermer P, Hamann GF, Seegers J, Gröschel K, Wachter R;
Find-AF (RANDOMISED) investigators. Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring – Find-AF (RANDOMISED) – rationale and design.
Am Heart J. 2014 Oct;168(4):438-445.e1. doi: 10.1016/j.ahj.2014.06.018.
Schneider A, Gutjahr-Lengsfeld L, Ritz E, Scharnagl H, Gelbrich G, Pilz S, Macdougall IC, Wanner C, Drechsler C.
Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients.
Nephron Clin Pract. 2014;128(1-2):147-52. doi: 10.1159/000367975.
Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B.
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
J Card Fail. 2014 Dec;20(12):923-30. doi: 10.1016/j.cardfail.2014.09.004.
Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E, Duvinage A, Unkelbach I, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Stough WG, Pieske BM.
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
Eur J Heart Fail. 2015 Feb;17(2):214-23. doi: 10.1002/ejhf.203.
Neumann A, Mostardt S, Biermann J, Gelbrich G, Goehler A, Geisler BP, Siebert U, Störk S, Ertl G, Angermann CE, Wasem J.
Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study.
Clin Res Cardiol. 2015 Apr;104(4):304-9. doi: 10.1007/s00392-014-0781-4.
Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, Maisch B, Prettin C, Brenner S, Morbach C, Berliner D, Deubner N, Ertl G, Angermann CE, Störk S;
Competence Network Heart Failure Germany. Reverse epidemiology in different stages of heart failure.
Int J Cardiol. 2015 Apr 1;184:216-24. doi: 10.1016/j.ijcard.2015.02.009.
Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Eur J Heart Fail. 2015 Apr;17(4):442-52. doi: 10.1002/ejhf.252.
Nolte K, Herrmann-Lingen C, Wachter R, Gelbrich G, Düngen HD, Duvinage A, Hoischen N, von Oehsen K, Schwarz S, Hasenfuss G, Halle M, Pieske B, Edelmann F.
Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.
Eur J Prev Cardiol. 2015 May;22(5):582-93. doi: 10.1177/2047487314526071.
Faller H, Störk S, Gelbrich G, Schowalter M, Ertl G, Angermann CE.
Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?
J Psychosom Res. 2015 Jun;78(6):569-72. doi: 10.1016/j.jpsychores.2015.02.015.
Piepenburg SM, Faller H, Gelbrich G, Störk S, Warrings B, Ertl G, Angermann CE.
Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure.
Circ Heart Fail. 2015 May;8(3):464-72. doi: 10.1161/CIRCHEARTFAILURE.114.001488.
Dekleva M, Lazic JS, Soldatovic I, Inkrot S, Arandjelovic A, Waagstein F, Gelbrich G, Cvijanovic D, Dungen HD.
Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial.
Cardiovasc Drugs Ther. 2015 Jun;29(3):287-94. doi: 10.1007/s10557-015-6590-9.
Seegers J, Zabel M, Grüter T, Ammermann A, Weber-Krüger M, Edelmann F, Gelbrich G, Binder L, Herrmann-Lingen C, Gröschel K, Hasenfuß G, Feltgen N, Pieske B, Wachter R.
Natriuretic peptides for the detection of paroxysmal atrial fibrillation.
Open Heart. 2015 Aug 3;2(1):e000182. doi: 10.1136/openhrt-2014-000182.
Pankuweit S, Lüers C, Richter A, Ruppert V, Gelbrich G, Maisch B;
German Competence Network Heart Failure. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
Eur J Clin Invest. 2015 Sep;45(9):906-17. doi: 10.1111/eci.12483.
Inkrot S, Lainscak M, Edelmann F, Loncar G, Stankovic I, Celic V, Apostolovic S, Tahirovic E, Trippel T, Herrmann-Lingen C, Gelbrich G, Düngen HD.
Poor self-rated health predicts mortality in patients with stable chronic heart failure.
Eur J Cardiovasc Nurs. 2015 Nov 3. pii: 1474515115615254. [Epub ahead of print]
Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolović S, Neskovic AN, Pieske B, Düngen HD;
CIBIS-ELD Investigators and Project Multicenter Trials in the Competence Network Heart Failure. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
JACC Heart Fail. 2016 Feb;4(2):140-9. doi: 10.1016/j.jchf.2015.10.008.
Hartwig M, Gelbrich G (korrespondierender Autor), Griewing B.
Functional orthosis in shoulder joint subluxation after ischaemic brain stroke to avoid post-hemiplegic shoulder-hand syndrome: a randomized clinical trial.
Clin Rehabil. 2012 Sep;26(9):807-16. doi: 10.1177/0269215511432355.
Gelbrich B, Hirsch A, Dannhauer KH, Gelbrich G.
Agenesis of second premolars and delayed dental maturation.
J Orofac Orthop. 2015 Jul;76(4):338-50. doi: 10.1007/s00056-015-0295-3.
Rau T, Düngen HD, Edelmann F, Waagstein F, Lainščak M, Dimković S, Apostolović S, Nešković AN, Haverkamp W, Gelbrich G, Eschenhagen T.
Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Clin Pharmacol Ther. 2012 Jul;92(1):21-8. doi: 10.1038/clpt.2012.18. Erratum in: Clin Pharmacol Ther. 2012 Sep;92(3):397.
Lehmkuhl E, Kendel F, Gelbrich G, Dunkel A, Oertelt-Prigione S, Babitsch B, Knosalla C, Bairey-Merz N, Hetzer R, Regitz-Zagrosek V.
Gender-specific predictors of early mortality after coronary artery bypass graft surgery.
Clin Res Cardiol. 2012 Sep;101(9):745-51. doi: 10.1007/s00392-012-0454-0.
Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen C, Anker SD, Düngen HD.
Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure – insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Int J Cardiol. 2012 Nov 29;161(3):160-5. doi: 10.1016/j.ijcard.2012.06.004.
Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD.
Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial.
Int J Cardiol. 2012 Nov 29;161(3):143-50. doi: 10.1016/j.ijcard.2011.09.007.
Dekleva M, Düngen HD, Gelbrich G, Inkrot S, Suzic Lazic J, Pavlovic Kleut M, Tahirovic E, Waagstein F.
Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure.
CIBIS-ELD sub-study. Aging Clin Exp Res. 2012 Dec;24(6):675-81. doi: 10.3275/8720.
Apostolovic S, Stanojevic D, Lainscak M, Gelbrich G, Jankovic-Tomasevic R, Pavlovic M, Djordjevic-Radojkovic D, Salinger-Martinovic S, Putnikovic B, Radovanovic S, Waagstein F, Tomasevic M, Tahirovic E, Inkrot S, Musial-Bright L, Düngen HD.
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Cardiol J. 2014;21(3):265-72. doi: 10.5603/CJ.a2013.0117.
Schneider A, Gutjahr-Lengsfeld L, Ritz E, Scharnagl H, Gelbrich G, Pilz S, Macdougall IC, Wanner C, Drechsler C.
Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients.
Nephron Clin Pract. 2014;128(1-2):147-52. doi: 10.1159/000367975.
Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B.
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
J Card Fail. 2014 Dec;20(12):923-30. doi: 10.1016/j.cardfail.2014.09.004.
Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B.
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
J Card Fail 2014 Dec;20(12):923-30. doi:10.1016/j.cardfail.2014.09.004. Epub 2014 Sep 16.
Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, Düngen HD, Pilz S, Binder L, Stahrenberg R, Schmidt A, März W, Pieske B.
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction.
Eur Heart J. 2012 Jan;33(2):203-12. [Epub 2011 Aug 19]
Angermann CE, Störk S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G; Competence Network Heart Failure.
Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study.
Circ Heart Fail. 2012 Jan;5(1):25-35. doi: 10.1161/CIRCHEARTFAILURE.111.962969. Epub 2011 Sep 28.
Loncar G, von Haehling S, Tahirovic E, Inkrot S, Mende M, Sekularac N, Lainscak M, Apostolovic S, Putnikovic B, Edelmann F, Wachter R, Dimkovic S, Waagstein F, Gelbrich G, Düngen HD.
Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.
Clin Biochem. 2012 Jan;45(1-2):117-22. [Epub 2011 Dec 2]
Gelbrich G, Edelmann F, Inkrot S, Lainscak M, Apostolovic S, Neskovic AN, Waagstein F, Loeffler M, Anker SD, Dietz R, Düngen HD; CIBIS-ELD investigators.
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Int J Cardiol. 2012 Feb 23;155(1):160-6. [Epub 2011 Nov 30]
Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S. Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure.
Clin Res Cardiol. 2012 Apr;101(4):263-72. [Epub 2011 Dec 3]
Wachter R, Lahno R, Haase B, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Gelbrich G, Görlitz A, Kermer P, Vollmann D, Hasenfuß G, Gröschel K, Stahrenberg R.
Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
PLoS One. 2012;7(4):e34351. doi: 10.1371/journal.pone.0034351. Epub 2012 Apr 11.